1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Bioinformatics

inDropSystem.jpg

1CellBio and Partek Deliver
Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface

LOUIS and CAMBRIDGE — 1/24/2019 — 1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize advanced Partek statistical and visualization tools for characterizing individual cells. In addition, users developing their own custom inDrop applications can take advantage of the wide variety of single cell bioinformatics tools available in the software and configure them using an intuitive interface.

Single cell analysis is growing in popularity within the life science community and provides exciting, novel insights into biological processes and diseases. It can be used in a wide variety of applications including tumor profiling, validation of drug targets, identification of cell-to-cell variation, and developmental lineage tracing. However, bioinformatics analysis remains a roadblock for many researchers. Traditional solutions require advanced computational skills or in-house informatics capabilities. Partek Flow solves this problem by enabling scientists to easily analyze their scRNA-Seq data with an intuitive point-and-click interface.

When asked about the partnership, Tom Downey, President of Partek said, “We are excited to work with 1CellBio to deliver an affordable and easy-to-use solution for analyzing single cell data, enabling scientists to ask and answer their own research questions without needing to learn and use command line tools”.

“We are delighted to partner with Partek,” said Colin J.H. Brenan, PhD, Chief Executive Officer, 1CellBio. “Not only do they offer the best in class scRNA-seq analysis solution today, but their continued innovation will meet our needs as we introduce additional single cell applications.”

You can watch a demonstration of the Partek Flow 1CellBio analysis pipeline in a joint webinar coming soon. Sign up for Partek webinar notifications to receive information about this webinar once available.

About Partek Incorporated
Partek Incorporated (www.partek.com) develops and globally markets quality analysis software and services for life sciences research. Partek software is unique in supporting all major next-generation sequencing and microarray platforms. Over seven thousand peer-reviewed scientific papers have used Partek software to streamline the analysis of genomic studies. Partek, headquartered in St. Louis, MO, USA, has been turning data into discovery® since 1993.

About 1CellBio

1CellBio Inc. is the leading single-cell analysis company serving the biomedical research community. The company’s flagship inDrop™ System, a high-resolution, single-cell transcriptomics platform, delivers greater experimental control, rare actionable information and lower overall cost per result compared to all other existing platforms. Research laboratories around the world are now adopting the platform for a wide range of single-cell applications from tumor profiling to stem cells to embryo development to the identification and validation of new drug targets. Founded by leading scientists at Harvard University, 1CellBio is based in Cambridge, MA, and the company supports its growing number of customers through a team of international sales and field application scientists. For more information, please visit www.1cell-bio.com.

Media Contacts

Kathi Gosche
Partek Incorporated
(314) 878-2329 x117
kgosche@partek.com

Andrew Noble
Noble Communications
(415) 722-2129
andrew_noble@noblecomms.com

# # # 

Partek, Partek Flow, and “turning data into discovery” are trademarks of Partek Incorporated. The names of other companies or products mentioned herein may be the trademarks of their respective owners.

Articles You May Like

Fish under threat release chemicals to warn others of danger
Othram Awarded Research Sequencing Grant At SXSW By Illumina Accelerator
Gene therapy restores immunity in infants with rare immunodeficiency disease
A novel data-compression technique for faster computer programs
Scientists use eBird data to propose optimal bird conservation plan

Leave a Reply

Your email address will not be published. Required fields are marked *